Adaptive Biotechnologies President and COO Julie Rubinstein Reports Sale of $897,355.59 in Common Shares
Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares Oct. 14-16, 2026. She exercised stock options for 35,643 common shares at $12.14 per share during the same period. Her direct common stock holdings remained at 377,802 shares; remaining stock options totaled 237,205. Disclaimer: This